Full-Dose Intraoperative Radiotherapy With Electrons During Breast-Conserving Surgery
- 1 July 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 242 (1), 101-106
- https://doi.org/10.1097/01.sla.0000167927.82353.bc
Abstract
Previous studies show that local recurrences after breast-conserving treatment occur in the site of the primary tumor. The need for postoperative radiotherapy on the whole breast is challenged in favor of radiotherapy limited to the area of the breast at high risk of recurrence. The new mobile linear accelerators easily moved close to the operating table to allow the full-dose irradiation during surgery. From July 1999 to December 2003, 590 patients affected by unifocal breast carcinoma up to a diameter of 2.5 cm received wide resection of the breast followed by intraoperative radiotherapy with electrons (ELIOT). Most patients received 21 Gy intraoperatively, biologically equivalent to 58 to 60 Gy in standard fractionation. Patients were evaluated 1, 3, 6, and 12 months after surgery, and thereafter every 6 months, to look for early, intermediate, late complications, and other events. After a follow-up from 4 to 57 months (mean, 24 months; median, 20 months), 19 patients (3.2%) developed breast fibrosis, mild in 18, severe in 1, which resolved within 24 months. Three patients (0.5%) developed local recurrences, 3 patients ipsilateral carcinomas in other quadrants and other 5 patients contralateral breast carcinoma. One patient (0.2%) died of distant metastases. ELIOT is a safe method for treating conservatively operated breasts, avoids the long period of postoperative radiotherapy, and reduces drastically the cost of radiotherapy. ELIOT reduces radiation to normal tissues and organs. Results on short-term and middle-term toxicity up to 5 years of follow-up are good. Data on local control are encouraging.Keywords
This publication has 36 references indexed in Scilit:
- Full-Dose Intraoperative Radiotherapy With Electrons During Breast-Conserving SurgeryArchives of Surgery, 2003
- A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast CancerThe New England Journal of Medicine, 2003
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerThe New England Journal of Medicine, 2002
- Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five‐year results of a phase I–II study and initial findings of a randomized phase III trialJournal of Surgical Oncology, 2002
- Surgical Technique of Intraoperative Radiotherapy in Conservative Treatment of Limited-Stage Breast CancerArchives of Surgery, 2002
- Intradermal Isotope Injection: A Highly Accurate Method of Lymphatic Mapping in Breast CarcinomaAnnals of Surgical Oncology, 2001
- Einfluss des Zeitintervalls Operation – Strahlentherapie auf die BehandlungsergebnisseStrahlentherapie und Onkologie, 2000
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyThe New England Journal of Medicine, 1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997